Laparoscopically assisted vaginal hysterectomy as definitive therapy for stage III and IV endometriosis.

Garrett Davis, G D Davis, G Wolgamott, Jei-Won Moon, J Moon
The Journal of reproductive medicine · 1993 · vol. 38(8) , pp. 577–81 · PMID:8410859 · W2412639279
article OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Laparoscopically assisted vaginal hysterectomy with ovarian removal and endometriosis excision effectively treated advanced endometriosis, with 97.5% of patients becoming symptom-free and acceptable complication rates.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Operative laparoscopy combined with vaginal hysterectomy and salpingo-oophorectomy was used to treat advanced endometriosis in 40 of 46 patients. This treatment plan was abandoned in favor of laparotomy in six patients. Of the 40 patients successfully treated by laparoscopically assisted vaginal hysterectomy, 39 are completely free of symptoms. Major complications, including blood loss requiring transfusion and injury to the ureter or bowel, were sustained at acceptable rates. No serious infections occurred. The mean operating time was 191 minutes. Laparoscopically assisted vaginal hysterectomy and removal of all ovarian tissue combined with excision of all endometriosis may be used as definitive therapy for advanced endometriosis. The major complications associated with surgical therapy for high-stage endometriosis are encountered; therefore, laparoscopic treatment requires advanced laparoscopic surgical skills.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Hysterectomy, Vaginal Laparoscopy Laparoscopy Adult Endometriosis Endometriosis Female Humans Hysterectomy, Vaginal Hysterectomy, Vaginal Intestines Intestines Intraoperative Complications Middle Aged Treatment Outcome Ureter Ureter

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (6)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:11:34.315996+00:00
License: CC0 · commercial use OK